Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01422382 · ClinicalTrials.gov registry record · Phase 4
Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin
A Phase 4 study of Healthy, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT01422382 is a Phase 4 study of Healthy that has completed, run by Kowa Research Institute. The registered enrollment target is 28 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01422382, a Phase 4 study of Healthy, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a Phase 4, single-center, open-label, fixed-sequence, multiple-dose, 2-way drug-drug interaction study.
Conditions Studied
Interventions
- DRUG Pitavastatin (NK-104)
- DRUG Diltiazem (Cardizem LA) 240 mg QD
Study Locations (1)
Texas
- - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01422382
The ClinicalTrials.gov registry entry for NCT01422382 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Pitavastatin (NK-104) is the first listed.
NCT01422382 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01422382 about?
NCT01422382 is a clinical study titled "Drug-Drug Interaction of Cardizem LA (Diltiazem Hydrochloride) on Pitavastatin". This is a Phase 4, single-center, open-label, fixed-sequence, multiple-dose, 2-way drug-drug interaction study.
What is the current status of trial NCT01422382?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2011-05. Estimated completion is 2011-07.
What conditions does trial NCT01422382 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT01422382?
The interventions under investigation include: Pitavastatin (NK-104) (DRUG), Diltiazem (Cardizem LA) 240 mg QD (DRUG).
Who is sponsoring clinical trial NCT01422382?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01422382 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation
RECRUITING · Phase 4
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
RECRUITING · Phase 4
-
Endothelial Derived Hyperpolarization Factor and Vascular Control
RECRUITING · Phase 4
-
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
ACTIVE NOT RECRUITING · Phase 4
-
Pharmacokinetics of Transdermal Metronidazole
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.